Amarin Corp Plc (AMRN)

[ziploc_1]

Older...The FDA CRL'd Anchor because it was not "obvious" to them that Vascepa would work...Amarin continued the R-IT study...at the risk of bankrupting the company, to show that chronic treatment with Vascepa over a FIVE YEAR period does, in fact, work!